Autopsy report · NCT02034968

Nimotuzumab Plus Nab-paclitaxel and Cisplatin in Treating Patients With Advanced Esophageal Carcinoma

“No recruitment”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

Zhejiang University

Sponsor type

University, hospital or other

Conditions

Stage IV Esophageal Squamous Cell Carcinoma

Interventions

Nimotuzumab

Participants

0

Sites

1

Countries

China

Trials that died the same way

• Mobile Phones in Cryptogenic Stroke Patients Bringing Single Lead ECGs to Detect Atrial Fibrillation
  “no personnel for recruitment” (86% match in meaning)
• Specific Enteral Nutrition in Malnourished, Dialysis Patients With Chronic Kidney Disease. Efficacy, Safety, Quality of Life
  “No Patient recruitment” (83% match in meaning)
• PRP ULCERAS: Clinical Trial Phase III
  “Without recruitment” (83% match in meaning)
• Value of Rituximab in Humoral Chronic Rejection After Renal Transplantation
  “lacking recruitment” (81% match in meaning)
• Hypogonadotropic Hypogonadism in Obese Young Males
  “not enough recruitment” (80% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.